Moran CORE

Open source ophthalmology education for students, residents, fellows, healthcare workers, and clinicians. Produced by the Moran Eye Center in partnership with the Eccles Library

Search Moran CORE

Fenofibrate; Effect on Diabetic Retinopathy, its Target and Mechanism of Action

HomeRetina and VitreousRetinal Vascular Disease: Diabetic Retinopathy

Title:  Fenofibrate;  Effect on Diabetic Retinopathy, its Target and Mechanism of Action
Author:  Jian-Zing Ma MD
Date:  04/16/2014
Keywords/Main Subjects: Diabetic retinopathy; Fenofibrate; PPAR-alpha
Diagnosis: Diabetic retinopathy
Brief Description: This is a research presentation of the effects of fenofibrate, a PPAR-alpha agonist, on diabtic retinopathy. The FIELD study and ACCORD studies of fenofibrate in diabetic retinopathy are discussed. The effect of fenofibrate in type I and type II diabetics is also discussed. Research into the pathogenesis of diabetic retinopathy and mechanism of action of fenofibrate is presented. The role of PPAR-alpha in the retina is also described.
Format: video
Series: Moran Eye Center Grand Rounds
Identifier: Moran_CORE_15518
Copyright statement: Copyright 2015. Please see terms of use page for more information.